期刊
NANO LETTERS
卷 18, 期 11, 页码 6655-6659出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.nanolett.8b02340
关键词
Nanomedicine; cancer immunotherapy; cancer vaccine; drug delivery; nanotechnology
类别
资金
- Mayo Clinic Center for Regenerative Medicine
- National Institute of Neurological Disorders and Stroke [R01 NS104315]
- Florida Center for Brain Tumor Research & Accelerate Brain Cancer Cure
- Cancer Prevention and Research Institute of Texas CPRIT [RR180017]
- National Natural Science Foundation of China [81572500]
- Hunan Young Talent [2016RS3036]
Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据